3 Competence Centre for Clinical Research, Skane University Hospital, Lund, Sweden 4 Department of Nephrology and Transplantation, Skane University Hospital Malmö, Lund University, Sweden Introduction ...
Objective To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2022 update of the ...
1 VU Medical Center, Department of Molecular Cell Biology & Immunology, Amsterdam, The Netherlands 2 Academic Medical Center, Division of Clinical Immunology and Rheumatology, University of Amsterdam, ...
Objective To evaluate whether subjects with knee or hip osteoarthritis (OA) pain on non-steroidal anti-inflammatory drugs (NSAIDs) received greater benefit when tanezumab monotherapy replaced or was ...
4 Leiden University Medical Center, Department of Orthopaedics, Leiden, Netherlands 5 Leiden University Medical Center, Department of Biomedical Data Sciences, Leiden, Netherlands Objectives The ...
Objectives The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the ...
Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...
Objectives Knee osteoarthritis (KOA) is a leading cause of global disability with conventional exercise yielding only modest improvements. Here we aimed to investigate the benefits of integrating ...
For personal accounts OR managers of institutional accounts * ...
SpA: Innovative techniques in spondyloarthritis research – Is there light at the end of the tunnel for our patients?
19 Department of Rheumatology, Internal Medicine III, Medical University of Vienna, Vienna, Austria 20 Department of Rheumatology, Radboud University, Nijmegen Medical Centre, Nijmegen, The ...
3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...